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1. Introduction 
Spontaneous abortion represents a common pregnancy adverse outcome and is a serious 
emotional burden for women. Loss of pregnancy is a distressing problem for both the 
patient and physician.   
The clinical diagnosis of threatened abortion is presumed when any bloody vaginal 
discharge or bleeding appears during the first trimester of pregnancy. A prospective 
study on women with threatened abortion reported that women older than 34 years had 
an odds ratio of 2.3 for miscarriage (Falco et al., 1996). Some women who bleed in early 
pregnancy, approximately half of them, will abort (Weiss et al., 2004). Occasionally, 
bleeding may persist for weeks, and then it becomes essential to decide whether there is 
any possibility of continuation of the pregnancy or not. The diagnosis of spontaneous 
abortion currently depends on a combination of ultrasonography and nine hormonal 
methods including serum human chorionic gonadotropin (HCG), estradiol (E2), estrone, 
estriol, progesterone, human placental lactogen, cortisol, urine HCG and urine estrogen 
(Gerhavd and Runnebaum 1984; Zeimet et al., 1998; Osmanagaoglu et al., 2010). Another 
parameter that could be used as a predictive marker for a spontaneous abortion or 
subsequent outcome of pregnancy is Cancer Antigen-125 (CA-125). This antigen is a cell 
surface high molecular weight glycoprotein. It is a mucin like coelomic antigen, which is 
detected in 80% of non-mucus epithelial carcinomas of ovary. This antigen is secreted 
from normal tissues, such as coelomic epithelium, amnion and their derivatives 
including respiratory system, mesenteric organs and epithelium of female genital system 
(Berek 2002). An increased CA-125 level is due to genital or non-genital origins. Non-
genital causes include hepatic diseases, peritonitis, renal failure, breast, colon and lung 
cancer, and tuberculosis. Genital causes include: pelvic inflammatory diseases, 
endometriosis, adenomyosis, leiomioma, ectopic pregnancy, endometrial and ovarian 
cancer. 
Serum CA-125 levels are increased in early pregnancy and immediately after birth 
(Cunningham 2005; Speroff and Fritz 2005), implicating the disintegration of the maternal 
decidua (i.e., blastocyst implantation and placental separation) as a possible source of the 
tumor marker elevation (Ayaty et al., 2007). There is a cyclic change in the serum 
concentration of CA-125 in normal menstruating women. It indicates that CA-125 was 
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produced from normal endometrium (Zeimet et al., 1993). Generation of potential 
immunogenic peptide (YTLDrDSLYV) derived from CA-125 that bind to human leukocyte 
antigen (HLA A2,1) leading to elicit peptide – specific human cytotoxic T lymphocytes that 
effectively kill ovarian tumors expressing CA-125 antigen (Kabawat et al., 1983; Bellon  et 
al., 2009) .      
Regarding the level of CA-125 in pregnancy, conflicting results have been reported. There 
is a positive correlation between CA-125 levels elevated 18-22 days after conception and 
spontaneous abortion, while repeated measurements at 6 weeks of gestation did not 
correlate with the outcome (Check et al., 1990). The distribution of CA-125 during 
pregnancy was highest in first trimester than second and third trimester (Brumsted et al., 
1988). This may be due to the secretion of CA-125 and placenta protein 14 (PP14) by the 
glandular epithelium of the endometrium (Julkunen et al., 1986a; Julkunen et al., 1986b; 
Dalton et al.,1995; Dalton et al.,1998). Serum concentration of these parameters may 
increase during the first trimester of pregnancy as the concentration of progesterone rise 
to a maximum in the first trimester. These observations suggest that CA-125 is 
synthesized by normal endometrium in non pregnant female and by deciduas in pregnant 
women (Jacobs et al., 1988). Quirk et al. (1988) hypothesized that decidual CA-125 gains 
access to the maternal compartment via a “tubal reflux” resulting in subsequent 
absorption via the peritoneal lymphatics. They speculated further that the drop in 
maternal serum CA-125 might well be related to a functional obstruction of the tubes that 
occurs as pregnancy advances, with fusion of the decidua capsularis and the decidua 
parietalis. 
The serum CA-125 level is higher in normal pregnancy compared to ectopic pregnancy 2-4 
weeks after a missed menses due to impaired interaction between the fetal trophoblast and 
tubal mucosa (Niloff et al., 1984; Sadovsky et al., 1991; Predanic 2000). Increase in serum 
CA-125 levels was found in patients with vaginal bleeding and impending spontaneous 
abortion due to extensive decidual destruction and trophoblast separation from decidual 
cells (Kobayashi et al., 1993). Sequential determinations of maternal CA-125 measurements 
appear to be a highly sensitive prognostic marker in the patients with viable pregnancy at 
an abortion risk (Schmidt et al., 2001). Transient elevation of the CA-125 level occurs in 
maternal serum during early pregnancy and just after delivery because of the destruction of 
decidual tissues may cause this transient elevation of CA-125 (Shin et al., 2003). Therefore 
the elevated serum CA-125 levels in women with normal intrauterine pregnancies may be  
clinically useful in early pregnancy monitoring. This test is rather sensitive to differentiate 
the normal pregnancy and threatened abortion. There was not a significant correlation 
between CA-125 levels and gestational weeks (Yamane et al., 1989). Consequently, an 
increase in serial CA-125 measurements in the follow-up of pregnancies with vaginal 
bleeding could be an early signal in determining the progression to the pregnancy loss. It 
had been found that women with symptoms of imminent abortion, who have a CA-125 level 
of ≥43.IU/ml, should be considered at a greater risk of miscarriage (Fiegler et al., 2003; 
Sotiriadis et al., 2004) (Table-1).  
Patients who eventually aborted had values of CA-125 more than 125 IU/ml while the 
control had a value not more than 93 IU/ml (Check et al., 1990; Ocer et al., 1992). In addition 
to that, an extremely high CA-125 level (over 2000 IU/mL) indicates a karyotype associated 
with fetal anomalies and CA-125 levels returned to normal after spontaneous abortion 
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eliminated the possibility that some other condition caused the marked increase (Munné et 
al., 1995). Although elevated CA-125 levels have been found previously in patients suffering 
from ovarian hyperstimulation syndrome and this merely reflect an increase in number of 
follicles (Bischof et al., 1989). Mordel et al. (1992) reported that CA-125 existed in significant 
amounts in the follicular fluid of periovulatory follicles of IVF and embryo transfer patients, 
but that there was no correlation between CA-125 concentrations and follicular fluid 
oestradiol, progesterone, testosterone, oocyte fertilization, embryo quality or pregnancy 
rates. It was stated that a possible ovarian tissue–blood barrier might preclude the passage 
of CA-125 from the follicular fluid to the serum (Fleuren et al., 1987). Endometrial 
receptivity is an important factor in IVF pregnancy success, and may be the origin of the 
changes in serum CA-125 that occur mostly from the endometrium. Bersinger et al. (1993) 
have investigated the considerable contribution of the endometrium to serum CA-125 
concentrations and found that it reflects a favourable endometrium. The ability to predict 
the chances of pregnancy before embryo transfer might assist clinicians in deciding whether 
embryos have a greater chance of implantation if they are transferred in a subsequent cycle. 
It was noted that CA-125 concentrations on the day of oocyte retrieval were the best 
predictors of pregnancy, with concentrations >10 IU/ml having an accuracy of 86.6% for 
pregnancy. Thus, in intracytoplasmic sperm injection cycles, women with high serum CA-
125 concentrations (>10 IU/ml) on the day of oocyte retrieval had very high pregnancy rates 
(Tavmergen et al., 2001) (Table 2).  
 
Favorable prognostic factors Adverse prognostic factors 
History 
Advancing gestational age Maternal age >34 years 
 
Increasing number of previous              
miscarriages 
Sonography 
Fetal heart activity at presentation Fetal bradycardia 
 
Discrepancy between gestational age         
and crown to rump length 
 Empty gestational sac >15-17 mm 
Maternal serum biochemistry 
Normal levels of these markers Free β-hCG value of 20 ng/ml 
 hCG increase <66% in 48 hrs 
 
Bioactive/immunoreactive ratio hCG        
<0.5 
 Progesterone <45 nmol/l in 1st trimester 
 Inhibin A <0.553 multiples of median 
 CA-125 level ≥43.1 U/mL in 1st trimester 
Table 1. Prognostic factors in cases of threatened abortion 
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Characteristic 
Non-pregnant 
mean ± SEM 
Pregnant 
mean ± SEM 
P Values 
No. of oocytes retrieved 7.58 ± 1.02 9.54 ± 0.92 NS 
No. of mature oocytes 4.98 ± 0.58 6.43 ± 0.54 NS 
Grade I embryo rates (%) 47.5 54.3 NS 
No. of embryos transferred 3.0 ± 0.3 4.66 ± 0.3 <0.001 
Peak oestradiol conc. (pg/ml) 1483.17 ± 129.9 2002.3 ± 114.8 0.004 
Endometrial thickness (mm) 12.6 ± 0.38 13.45 ± 0.42 NS 
NS: not significant (t test and x2 test; P > 0.05). 
Table 2. Value of serum CA-125 concentrations as predictors of pregnancy in assisted 
reproduction cycles 
An observation suggests CA-125 correlates less well with endometrial development in 
women suffering from recurrent miscarriage (Scrapellini et al., 1995). The concentration of 
CA-125 in the pregnant women who subsequently aborted were higher than those who did 
not, thus suggesting that serum CA-125 are not so important in maintaining successful 
pregnancy (Azogui et al., 1996). CA-125 may be useful in the assessment of endometrial 
development in recurrent miscarriage patients and this suggested the importance in 
preparing the endometrium for embryo implantation (Yu et al., 2008). High level of serum 
CA-125 with high lactate dehydrogenase indicates more extensive trophoblastic tissue 
damage (Madendag et al., 2008). Some found that single serum CA-125 level determinations 
is valuable in women with imminent abortion presenting with abdominal pain, vaginal 
bleeding or both while others are in disagreement with this result (Fiegler et al., 2003). 
Possibly it may be attributed to the method of CA-125 measurement like the 
radioimmunoassay or the enzyme immune sorbent assay method. 
The prognostic predictive value of maternal serum CA-125 measurement in threatened 
abortion can be useful to determine the extent of decidual destruction which is directly 
related to the outcome of pregnancy. So one can conclude a hypothesis of a tropho-decidual 
origin of this marker suggesting its possible usefulness in the prognostic evaluation of first 
trimester threatened abortion. To predict the outcome of patients with threatened abortion 
at an early stage of gestation is clinically important. CA-125 and hormones associated with 
pregnancy  serum human chorionic gonadotropin beta-subunit, serum progesterone, serum 
cortisol, serum human placental lactogen, serum estrone, serum estradiol, serum estriol, 
urine human chorionic gonadotropin progesterone, inhibin A, and urine estrogen. Serum 
CA-125 concentrations may be helpful as predictors and serve as a judge of good prognosis 
in threatened abortion indicators in association with other tests like ultrasonography 
because others found  that serum CA-125 levels are not predictive of spontaneous abortion 
in the first trimester and failed to discriminate among missed abortions, threatened 
abortions, and normal pregnancies (Mahdi 2010) (Table 3).  
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Test 
Group I 
End with abortion 
n=42 
Group II 
Normal pregnancy 
n=20 
Serum Ca-125 
Cut-off value 
up to 30 IU/ml 
39.9±15.4 28.03±4.5 
p-value NS NS 
Table 3. Level of CA-125 in the serum of pregnant women expressed as mean ± standard 
error mean 
The single measurement of free beta-hCG or progesterone levels can be useful in the 
prediction of first trimester spontaneous abortions, but using progesterone may be 
recommended since it has high availability and low cost.  
As a conclusion, the measurement of serum CA-125 is not of value to predict the outcome of 
threatened abortion because it is secreted from different origins. There is no correlation 
between CA-125 level and outcome of pregnancy. CA-125 may have a predictive role in the 
successful outcome in ICSI cycles, but it has to be further investigated 
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